Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Braz. j. microbiol ; 49(4): 856-864, Oct.-Dec. 2018. graf
Article in English | LILACS | ID: biblio-974294

ABSTRACT

ABSTRACT The growth of yeasts in culture media can be affected by many factors. For example, methanol can be metabolized by other pathways to produce ethanol, which acts as an inhibitor of the heterologous protein production pathway; oxygen concentration can generate aerobic or anaerobic environments and affects the fermentation rate; and temperature affects the central carbon metabolism and stress response protein folding. The main goal of this study was determine the implication of free fatty acids on the production of heterologous proteins in different culture conditions in cultures of Pichia pastoris. We evaluated cell viability using propidium iodide by flow cytometry and thiobarbituric acid reactive substances to measure cell membrane damage. The results indicate that the use of low temperatures and low methanol concentrations favors the decrease in lipid peroxidation in the transition phase from glycerol to methanol. In addition, a temperature of 14 ºC + 1%M provided the most stable viability. By contrast, the temperature of 18 ºC + 1.5%M favored the production of a higher antibody fragment concentration. In summary, these results demonstrate that the decrease in lipid peroxidation is related to an increased production of free fatty acids.


Subject(s)
Pichia/metabolism , Fatty Acids, Nonesterified/metabolism , Pichia/growth & development , Pichia/genetics , Temperature , Recombinant Proteins/genetics , Culture Media/metabolism , Culture Media/chemistry , Methanol/metabolism , Fermentation , Glycerol/metabolism
2.
Braz. j. microbiol ; 44(4): 1043-1048, Oct.-Dec. 2013. ilus
Article in English | LILACS | ID: lil-705251

ABSTRACT

Since the 1970s, the establishment and development of the biotech industry has improved exponentially, allowing the commercial production of biopharmaceutical proteins. Nowadays, new recombinant protein production is considered a multibillion-dollar market, in which about 25% of commercial pharmaceuticals are biopharmaceuticals. But to achieve a competitive production process is not an easy task. Any production process has to be highly productive, efficient and economic. Despite that the perfect host is still not discovered, several research groups have chosen Pichia pastoris as expression system for the production of their protein because of its many features. The attempt of this review is to embrace several research lines that have adopted Pichia pastoris as their expression system to produce a protein on an industrial scale in the health care industry.


Subject(s)
Humans , Biotechnology/methods , Health Care Sector , Industrial Microbiology/methods , Organisms, Genetically Modified , Pichia/genetics , Pichia/metabolism , Technology, Pharmaceutical/methods
SELECTION OF CITATIONS
SEARCH DETAIL